Companion Animal Welfare

Cat Immune-Mediated Disease Welfare

Immune-mediated diseases in cats including immune-mediated haemolytic anaemia and thrombocytopenia require intensive management.

Key Facts

Immune-mediated anaemia (IMHA) is less common in cats than dogs but occurs with serious welfare impact
Secondary IMHA in cats is often associated with FeLV, FIV or Mycoplasma infection
Treatment requires immunosuppression with careful monitoring for side effects
Blood transfusion may be needed as emergency stabilisation before immunosuppression takes effect
Prognosis is variable and honest prognostic discussions support welfare-aligned decision making

Welfare Considerations

Feline IMHA causes acute welfare compromise from severe anaemia. Treatment is intensive and carries side effect risks. Honest prognostic assessment helps owners make informed welfare decisions about treatment intensity versus palliative options.

What You Can Do

Seek emergency specialist care for cats with acute severe anaemia from suspected IMHA
Discuss prognosis and treatment intensity options honestly with your specialist
Monitor for relapses and maintain vigilance for secondary infections during immunosuppression